V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014500 | 260009848 | 1.7 | 72 | Palliative (P) | 2016-06-08 | 2016-06-08 | CISPLATIN + EPIRUBICIN | N | N | 260029857 | IVA |
| 260014501 | 260009848 | 1.81 | 81 | Adjuvant (A) | 2016-06-28 | 2016-08-08 | BLEOMYCIN + VINCRISTINE | 02 | N | 260029857 | IFOSFAMIDE + PACLITAXEL |
| 260014502 | 260009849 | 1.83 | 95.1 | Curative (C) | 2017-12-12 | 2017-12-12 | BLEOMYCIN | N | N | 260029872 | EP |
| 260014503 | 260009850 | 1.8 | 67.3 | Curative (C) | 2017-12-26 | 2018-04-17 | VIP | N | N | 260029877 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014504 | 260009853 | 1.82 | 97 | Palliative (P) | 2015-09-25 | 2015-10-20 | Alemtuz+Cyclophos+Fludara Allo | N | N | 260029878 | TRABECTEDIN |
| 260014505 | 260009854 | 1.74 | 92.9 | Disease modification (D) | 2016-10-27 | 2016-10-28 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 2 | N | 260029894 | CARBO + THIOTEPA + TOPOTECAN |
| 260014506 | 260009856 | 1.8 | 81.4 | Curative (C) | 2017-05-13 | 2017-06-01 | Vinblastine weekly | N | N | 260029894 | PACLITAXEL |
| 260014507 | 260009857 | 0 | 52 | Curative (C) | 2015-10-09 | 2015-10-09 | BLEOMYCIN | 2 | N | 260029906 | CISPLATIN + EPIRUBICIN |
| 260014508 | 260009858 | 0 | 81.5 | Disease modification (D) | null | 2019-04-16 | CYCLOPHOSPHAMIDE | N | N | 260029907 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014509 | 260009859 | null | 115 | Curative (C) | 2017-09-10 | 2017-09-11 | STS Rhabdomyosarcoma RMS 2005 VA | N | null | 260029909 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260014510 | 260009859 | 1.91 | 66 | Palliative (P) | 2018-05-21 | 2018-05-21 | Gemcitabine + Paclitaxel | N | N | 260029909 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014511 | 260009860 | 1.69 | 111.7 | Disease modification (D) | null | 2018-01-04 | ACE (germ cell) | null | null | 260029926 | R IVAC |
| 260014512 | 260009861 | 1.87 | null | null | 2016-02-03 | 2016-02-03 | ACE (germ cell) | null | null | 260029943 | GDP |
| 260014513 | 260009862 | null | null | null | 2014-03-06 | 2014-03-06 | ECX | null | null | 260029946 | GEMCARBO |
| 260014514 | 260009862 | 1.83 | null | Curative (C) | 2016-05-07 | 2016-06-19 | CISPLATIN + METHOTREXATE + VINCRISTINE | null | null | 260029946 | BLEOMYCIN + VINCRISTINE |
| 260014515 | 260009863 | null | null | Curative (C) | 2016-08-27 | 2016-09-29 | BLEOMYCIN + VINCRISTINE | N | N | 260029958 | PCV |
| 260014516 | 260009864 | 1.77 | 71.5 | Disease modification (D) | 2017-07-14 | 2017-07-15 | BOP | 2 | N | 260029958 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL |
| 260014517 | 260009870 | 1.85 | null | null | 2018-01-08 | 2018-01-14 | Vinblastine weekly | null | null | 260029960 | CISPLATIN + VINORELBINE |
| 260014518 | 260009870 | null | 72.3 | null | null | 2015-09-29 | STS Rhabdomyosarcoma RMS 2005 VA | null | N | 260029960 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260014519 | 260009874 | 1.87 | 69 | Palliative (P) | 2014-10-25 | 2014-10-25 | STS Rhabdomyosarcoma RMS 2005 VA | 2 | N | 260030000 | ACE (GERM CELL) |
| 260014520 | 260009874 | null | null | Palliative (P) | 2014-02-06 | 2014-02-06 | IFOSFAMIDE + PACLITAXEL | N | N | 260030000 | VINCRISTINE |
| 260014521 | 260009875 | 1.75 | 101 | Palliative (P) | 2016-03-22 | 2016-03-28 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | 02 | N | 260030004 | IPO |
| 260014522 | 260014695 | null | 83.3 | null | null | 2017-11-14 | CHLORAMBUCIL + OBINUTUZUMAB | null | null | 260030014 | IPO |
| 260014523 | 260009877 | 1.83 | 65.3 | Disease modification (D) | 2015-11-15 | 2016-01-23 | POMB | 02 | null | 260030014 | GEMCITABINE + OXALIPLATIN |
| 260014524 | 260009881 | 1.65 | 89 | Curative (C) | 2014-10-22 | 2014-10-22 | VIP | 02 | N | 260030021 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260014525 | 260009882 | 1.9 | null | Curative (C) | 2016-02-04 | 2016-02-04 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | N | N | 260030024 | IVA |
| 260014526 | 260009882 | 1.81 | null | null | 2014-08-26 | 2014-08-31 | ACE (germ cell) | N | null | 260030024 | EP |
| 260014527 | 260009882 | 1.78 | null | Disease modification (D) | 2015-02-13 | 2015-02-13 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | N | N | 260030024 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014528 | 260009884 | 1.7 | 76.5 | Disease modification (D) | 2017-05-02 | 2017-06-18 | BLEOMYCIN | N | N | 260030041 | BLEOMYCIN |
| 260014529 | 260017050 | null | 75.6 | Curative (C) | 2015-12-12 | 2015-12-13 | CISPLATIN + IFOSFAMIDE + MESNA + VINBLASTINE | N | N | 260030041 | CYTARABINE + METHOTREXATE HD |
| 260014530 | 260009887 | 1.6 | 72.1 | Curative (C) | 2018-04-15 | 2018-04-15 | Cisplatin 7 day | N | N | 260030043 | CISPLATIN |
| 260014531 | 260009887 | 1.5 | 51.4 | Palliative (P) | 2016-11-13 | 2016-12-21 | CISPLATIN + GEMCITABINE + RITUXIMAB | 01 | null | 260030043 | CETUXIMAB |
| 260014532 | 260018224 | null | null | Curative (C) | 2014-11-17 | 2014-12-09 | BLEOMYCIN | N | N | 260030052 | CISPLATIN |
| 260014533 | 260018811 | 1.72 | 89 | Curative (C) | 2015-02-15 | 2015-08-23 | Gemcitabine + Oxaliplatin | N | N | 260030059 | BLEOMYCIN |
| 260014534 | 260014701 | 1.75 | 79 | Curative (C) | 2018-05-04 | 2018-05-22 | ACE (germ cell) | Y | N | 260030065 | BLEOMYCIN |
| 260014535 | 260014702 | 1.73 | null | Disease modification (D) | 2018-12-12 | 2018-12-26 | VIP | N | N | 260030070 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014537 | 260009895 | null | 61 | Palliative (P) | 2017-04-29 | 2017-05-10 | Cisplatin 7 day | N | N | 260030077 | CHOP |
| 260014538 | 260009897 | 1.67 | 56.6 | Disease modification (D) | 2016-09-16 | 2016-10-28 | CHOP - 21 days | 02 | N | 260030078 | CARBOPLATIN + PACLITAXEL |
| 260014539 | 260014706 | null | 88.8 | Not known (9) | 2016-01-15 | 2016-01-15 | Cytarabine HD + Methotrexate HD | N | N | 260030080 | IFOSFAMIDE + PACLITAXEL |
| 260014540 | 260009899 | null | null | Curative (C) | 2018-07-27 | 2018-07-28 | BLEOMYCIN | 02 | N | 260030083 | BLEOMYCIN |
| 260014541 | 260014707 | 1.83 | null | Curative (C) | 2015-05-10 | 2015-05-24 | CARBOPLATIN + ETOPOSIDE | N | N | 260030087 | BLEOMYCIN |
| 260014542 | 260009900 | 1.7 | 64.5 | null | 2013-10-27 | 2013-10-28 | CYCLOPHOSPHAMIDE | N | N | 260030092 | IBRUTINIB |
| 260014543 | 260009901 | null | 60.8 | Curative (C) | 2015-03-08 | 2015-06-01 | Cisplatin 7 day | 02 | null | 260030095 | TRASTUZUMAB |
| 260014544 | 260009905 | 1.7 | 87.1 | Disease modification (D) | 2017-10-06 | 2017-10-12 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | N | 260030098 | IVA |
| 260014545 | 260009905 | null | 85.2 | Disease modification (D) | 2017-06-10 | 2017-07-18 | IFOSFAMIDE + PACLITAXEL | N | null | 260030098 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260014546 | 260009905 | 1.69 | null | Disease modification (D) | 2014-03-08 | 2014-03-23 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + PACLITAXEL | 2 | N | 260030098 | CISPLATIN + EPIRUBICIN |
| 260014547 | 260009905 | 1.72 | 66 | Curative (C) | 2013-04-19 | 2013-04-21 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 260030098 | CHOP |
| 260014548 | 260009906 | 1.61 | null | Palliative (P) | null | 2014-03-15 | CVP | 2 | N | 260030114 | CISPLATIN |
| 260014549 | 260009906 | 1.8 | 92.4 | Curative (C) | 2015-02-02 | 2015-02-07 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260030114 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260014550 | 260009906 | null | 95.6 | Disease modification (D) | 2014-06-29 | 2014-06-30 | BLEOMYCIN + CISPLATIN + VINCRISTINE | 02 | Y | 260030114 | CISPLATIN + ETOPOSIDE + PACLITAXEL |